Similar articles for PMID: 31643472

Year	Number of Results
1996	1
1997	1
1998	8
1999	10
2000	19
2001	19
2002	7
2003	7
2004	3
2005	5
2006	5
2007	2
2008	4
2009	1
2010	2
2011	1
2012	2
2013	2
2017	1
2018	4
2019	2
2021	1
2024	0

1

[No authors listed] [No authors listed] 2018 Jun 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jun 6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643472 Free Books & Documents. Review.

2

Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.

Graham DJ, Drinkard CR, Shatin D. Graham DJ, et al. Am J Gastroenterol. 2003 Jan;98(1):175-9. doi: 10.1111/j.1572-0241.2003.07175.x. Am J Gastroenterol. 2003. PMID: 12526954

3

Hepatotoxicity with thiazolidinediones: is it a class effect?

Scheen AJ. Scheen AJ. Drug Saf. 2001;24(12):873-88. doi: 10.2165/00002018-200124120-00002. Drug Saf. 2001. PMID: 11735645 Review.

4

Increased susceptibility to troglitazone-induced mitochondrial permeability transition in type 2 diabetes mellitus model rat.

Segawa M, Sekine S, Sato T, Ito K. Segawa M, et al. J Toxicol Sci. 2018;43(5):339-351. doi: 10.2131/jts.43.339. J Toxicol Sci. 2018. PMID: 29743445 Free article.

5

Troglitazone-induced liver failure: a case study.

Graham DJ, Green L, Senior JR, Nourjah P. Graham DJ, et al. Am J Med. 2003 Mar;114(4):299-306. doi: 10.1016/s0002-9343(02)01529-2. Am J Med. 2003. PMID: 12681458

6

Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.

Ogimura E, Nakagawa T, Deguchi J, Sekine S, Ito K, Bando K. Ogimura E, et al. Toxicol Sci. 2017 Aug 1;158(2):347-355. doi: 10.1093/toxsci/kfx091. Toxicol Sci. 2017. PMID: 28486596

7

A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T. Watanabe I, et al. Clin Pharmacol Ther. 2003 May;73(5):435-55. doi: 10.1016/s0009-9236(03)00014-6. Clin Pharmacol Ther. 2003. PMID: 12732844

8

Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities.

Ong MM, Latchoumycandane C, Boelsterli UA. Ong MM, et al. Toxicol Sci. 2007 May;97(1):205-13. doi: 10.1093/toxsci/kfl180. Epub 2006 Dec 5. Toxicol Sci. 2007. PMID: 17150972

9

Troglitazone.

Yokoi T. Yokoi T. Handb Exp Pharmacol. 2010;(196):419-35. doi: 10.1007/978-3-642-00663-0_14. Handb Exp Pharmacol. 2010. PMID: 20020270 Review.

10

Liver enzyme monitoring in patients treated with troglitazone.

Graham DJ, Drinkard CR, Shatin D, Tsong Y, Burgess MJ. Graham DJ, et al. JAMA. 2001 Aug 15;286(7):831-3. doi: 10.1001/jama.286.7.831. JAMA. 2001. PMID: 11497537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year